VERSEAU THERAPEUTICS
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.
VERSEAU THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2017-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.verseautx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
54.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Stoke Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.
Current Employees Featured
Founder
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Verseau Therapeutics
Highlight Capital
Highlight Capital investment in Venture Round - Verseau Therapeutics
3sbio
3sbio investment in Venture Round - Verseau Therapeutics
Yonghua Capital
Yonghua Capital investment in Venture Round - Verseau Therapeutics
InHarv Partners
InHarv Partners investment in Venture Round - Verseau Therapeutics
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research investment in Venture Round - Verseau Therapeutics
20/20 HealthCare Partners
20/20 HealthCare Partners investment in Venture Round - Verseau Therapeutics
Key Employee Changes
Official Site Inspections
http://www.verseautx.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.59 K
- Host name: 222.116.212.35.bc.googleusercontent.com
- IP address: 35.212.116.222
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
